Glutathione IV Treatment: Biomarkers & Genetic Factors

Q: What is the difference between oral glutathione supplements and IV glutathione therapy?

Oral glutathione has poor absorption due to enzymatic degradation in the GI tract; bioavailability is typically <10%. IV glutathione bypasses digestion, achieving higher plasma concentrations within minutes. IV delivery is more reliable for acute antioxidant support, though both modalities have clinical applications depending on goals.

Q: How often should someone receive glutathione IV infusions for optimal benefit?

Frequency varies based on baseline biomarkers, clinical goals, and individual response. Common protocols range from weekly to monthly infusions. Your provider should monitor oxidative stress markers and functional improvements to determine if current frequency is effective or requires adjustment.

Q: Can I use PlexusDx genetic testing to determine if glutathione IV is right for me?

PlexusDx's Precision Peptide Genetic Test reveals genetic predispositions in antioxidant enzyme pathways, which can inform provider conversations about oxidative stress management. However, genetic testing alone does not diagnose need for IV glutathione—biomarker assessment and clinical evaluation are essential partners in that decision.

Q: Are there side effects or safety concerns with regular glutathione IV infusions?

IV glutathione is generally well-tolerated with minimal side effects. Rare reactions include mild nausea, headache, or localized vein irritation. Contraindications include severe renal disease and chemotherapy regimens sensitive to glutathione. A qualified provider should assess kidney and liver function before starting treatment.

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Glutathione IV treatment delivers a powerful antioxidant directly into the bloodstream to support cellular detoxification and oxidative stress reduction. Individual response depends significantly on baseline glutathione status, mitochondrial function markers, and genetic predispositions affecting antioxidant pathways.

Before starting any IV therapy, understanding your personal biomarker context and genetic background can help support a more informed conversation with your healthcare provider. PlexusDx emphasizes precision wellness—matching treatments to individual biology rather than population averages.

How Glutathione IV Works at the Cellular Level

Glutathione is a tripeptide antioxidant that neutralizes reactive oxygen species (ROS) and supports phase II detoxification in the liver. IV administration bypasses first-pass metabolism, delivering higher bioavailable concentrations than oral supplementation. Peak plasma levels occur within minutes of infusion.

The primary mechanism involves the glutathione peroxidase enzyme system, which reduces hydrogen peroxide and organic hydroperoxides to water and alcohols. This process regenerates other antioxidants like vitamin C and E, creating a cascading protective effect across multiple cellular compartments.

Biomarker Assessment Before and After IV Glutathione

Clinical readiness for glutathione IV therapy should include baseline evaluation of oxidative stress markers, liver function tests, and kidney clearance capacity. Common biomarkers that inform treatment decision-making include oxidized glutathione (GSSG), total antioxidant capacity (TAC), and malondialdehyde (MDA) levels. A qualified provider can determine which markers are most relevant for your health goals.

Biomarker	Clinical Relevance	Normal Range Consideration	IV Glutathione Impact
Oxidized Glutathione (GSSG)	Indicates current oxidative burden; elevated GSSG suggests active cellular stress	Typically <2 μmol/L	May decrease with repeated dosing as antioxidant reserves replenish
Total Antioxidant Capacity (TAC)	Reflects overall antioxidant defense system strength; lower TAC indicates less capacity to neutralize free radicals	Varies by lab; >1.3 mmol/L desirable	May improve transiently; sustained benefit depends on lifestyle and dietary antioxidant intake
Malondialdehyde (MDA)	Measures lipid peroxidation; elevated MDA indicates advanced oxidative damage to cell membranes	Typically <3 μmol/L	Potential reduction with adequate glutathione repletion and mitochondrial support
Liver Function Panel (AST, ALT, GGT)	Ensures detoxification capacity and safe tolerance of IV therapy; high GGT may indicate ongoing oxidative stress	AST/ALT <40 IU/L; GGT <65 IU/L	Should remain stable; abnormal trends warrant provider discussion before continuing treatment

Genetic Factors Affecting Glutathione Metabolism and IV Response

Several genes regulate glutathione synthesis, recycling, and utilization. Variants in GCLC (glutamate-cysteine ligase catalytic subunit), GCLM (modifier subunit), and GSS (glutathione synthetase) influence baseline glutathione production capacity. Additionally, polymorphisms in genes encoding phase II enzymes like GSTP1 affect how efficiently cells use exogenous glutathione.

The MTHFR gene variant affects methylation capacity and downstream cofactor availability for antioxidant enzymes, potentially influencing whether IV glutathione addresses root causes or merely supplements temporary defense. SOD2 variants (manganese superoxide dismutase) also modulate mitochondrial antioxidant efficiency, affecting how well cells respond to exogenous glutathione support.

Safety Considerations and Clinical Readiness Framework

Glutathione IV is generally well-tolerated, but contraindications include severe kidney disease, platinum-based chemotherapy regimens, and certain autoimmune conditions. Pre-existing allergies to sulfur-containing compounds warrant discussion with your provider. Dosing typically ranges from 500 mg to 2.5 g per infusion, administered weekly to monthly depending on clinical goals and response.

A qualified healthcare provider should assess your kidney function, liver baseline, current medications (especially those dependent on glutathione metabolism), and underlying health conditions before initiating treatment. Frequency and duration of therapy should be individualized based on biomarker response and clinical outcomes, not arbitrary protocols.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals genetic predispositions in oxidative stress pathways and antioxidant enzyme function. Variants in genes like SOD2, GCLC, and GSTP1 may help provide context for how efficiently your cells produce and recycle glutathione. This information should be interpreted with a qualified healthcare provider to inform personalized antioxidant strategy.

The genetic test does not predict exact glutathione IV response or guarantee treatment success. Instead, it identifies which genetic variants you carry that influence baseline antioxidant capacity, mitochondrial function, and phase II detoxification efficiency. This predisposition data can support a more informed conversation about whether IV glutathione addresses your specific biochemical pattern.

Understanding your genetic and biomarker context allows for more targeted treatment planning. Rather than assuming all patients need identical glutathione protocols, a provider can use your genetic predispositions and baseline oxidative stress markers to determine appropriate dosing, frequency, and combination therapies. PlexusDx emphasizes precision wellness—matching interventions to individual biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between oral glutathione supplements and IV glutathione therapy?

Oral glutathione has poor absorption due to enzymatic degradation in the GI tract; bioavailability is typically <10%. IV glutathione bypasses digestion, achieving higher plasma concentrations within minutes. IV delivery is more reliable for acute antioxidant support, though both modalities have clinical applications depending on goals.

How often should someone receive glutathione IV infusions for optimal benefit?

Frequency varies based on baseline biomarkers, clinical goals, and individual response. Common protocols range from weekly to monthly infusions. Your provider should monitor oxidative stress markers and functional improvements to determine if current frequency is effective or requires adjustment.

Can I use PlexusDx genetic testing to determine if glutathione IV is right for me?